An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Top Cited Papers
- 11 June 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 24 (7), 1036-1046
- https://doi.org/10.1038/s41591-018-0052-4
Abstract
Metabolic reprograming is an emerging hallmark of tumor biology and an actively pursued opportunity in discovery of oncology drugs. Extensive efforts have focused on therapeutic targeting of glycolysis, whereas drugging mitochondrial oxidative phosphorylation (OXPHOS) has remained largely unexplored, partly owing to an incomplete understanding of tumor contexts in which OXPHOS is essential. Here, we report the discovery of IACS-010759, a clinical-grade small-molecule inhibitor of complex I of the mitochondrial electron transport chain. Treatment with IACS-010759 robustly inhibited proliferation and induced apoptosis in models of brain cancer and acute myeloid leukemia (AML) reliant on OXPHOS, likely owing to a combination of energy depletion and reduced aspartate production that leads to impaired nucleotide biosynthesis. In models of brain cancer and AML, tumor growth was potently inhibited in vivo following IACS-010759 treatment at well-tolerated doses. IACS-010759 is currently being evaluated in phase 1 clinical trials in relapsed/refractory AML and solid tumors.Keywords
This publication has 54 references indexed in Scilit:
- Fundamentals of cancer metabolismScience Advances, 2016
- Importance of Glutamine Metabolism in Leukemia Cells by Energy Production Through TCA Cycle and by Redox HomeostasisCancer Investigation, 2014
- Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stressBMC Cancer, 2014
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh CellsCancer Cell, 2013
- Heterogeneity of tumor-induced gene expression changes in the human metabolic networkNature Biotechnology, 2013
- Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITFCancer Cell, 2013
- Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell LymphomaCancer Cell, 2012
- 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast CancersCancer Research, 2011
- Otto Warburg's contributions to current concepts of cancer metabolismNature Reviews Cancer, 2011
- THE METABOLISM OF TUMORS IN THE BODYThe Journal of general physiology, 1927